Fatigue and low libido show up the same way on paper regardless of where the problem started, and that is exactly why a testosterone number by itself cannot tell you what is actually happening inside your body. Primary and secondary hypogonadism produce nearly identical symptoms but originate in different parts of the endocrine system, and telling them apart requires one additional lab value that most men have never heard of before their first hormone panel.
Table of Contents
- What Hypogonadism Means and Why the Cause Matters
- Primary Hypogonadism Originates in the Testes
- Secondary Hypogonadism Originates in the Brain's Signaling Centers
- How LH and FSH Distinguish the Two Types on a Lab Panel
- Primary vs Secondary Hypogonadism at a Glance
- Additional Testing That Refines the Diagnosis
- Why the Distinction Changes the Care Plan
- When to Talk to a Clinician About Low Testosterone Symptoms
- FAQ
What Hypogonadism Means and Why the Cause Matters
Hypogonadism is the clinical term for a testosterone level below the reference range that also comes with symptoms such as fatigue, low libido, or reduced muscle mass. A single low number on a lab report is not, by itself, a diagnosis.
The same lab result, a low testosterone reading, can originate from two entirely different places in the body's hormone signaling chain: the testes themselves, or the brain centers that instruct the testes to produce testosterone in the first place. That distinction is not academic. It changes the further workup a clinician orders, the treatment options on the table, and, for men who want children, the fertility conversation that follows.
A single testosterone draw cannot tell a clinician which type is present. A second hormone, luteinizing hormone (LH), is what actually separates the two.
Primary Hypogonadism Originates in the Testes
Primary hypogonadism means the testes themselves cannot produce adequate testosterone despite receiving normal signaling from the brain. The problem sits at the factory, not the messaging system.
When testosterone output falls, the pituitary gland senses the shortfall and responds by raising luteinizing hormone (LH) and follicle-stimulating hormone (FSH), a pattern clinicians call hypergonadotropic hypogonadism, according to StatPearls (NCBI, 2024). The elevated LH and FSH represent the brain shouting louder because the testes are not answering.
Common drivers of primary hypogonadism include:
- Klinefelter syndrome (a congenital chromosomal condition)
- Testicular injury or trauma
- Mumps orchitis
- Chemotherapy or radiation exposure
- Age-related testicular decline
Because sperm production happens in the same testicular tissue as testosterone production, fertility is frequently affected alongside hormone levels in primary hypogonadism.
Secondary Hypogonadism Originates in the Brain's Signaling Centers
Secondary hypogonadism describes the opposite scenario: the testes are structurally capable of normal function, but the hypothalamus or pituitary gland fails to send the signal that would prompt them to produce testosterone.
On labs, this looks like LH and FSH that are low or inappropriately normal despite a confirmed low testosterone level, a pattern described by both Mayo Clinic and Cleveland Clinic (2026). Mayo Clinic frames it directly: the testicles appear typical, but they do not function correctly because they are not being told to.
Frequent causes include:
- Pituitary tumors
- Obesity-related suppression of the hypothalamic-pituitary-gonadal axis
- Chronic opioid use
- Elevated prolactin
- Genetic conditions such as Kallmann syndrome
Because the problem is the signal rather than the factory, some secondary causes are at least partly reversible once the underlying driver is addressed, weight change, medication adjustment, or treatment of a hormone-secreting tumor among them.
How LH and FSH Distinguish the Two Types on a Lab Panel
Clinicians pair a morning total testosterone draw with LH and FSH to read the feedback loop as a whole, not the testosterone number in isolation. Testosterone tells you that something is low. LH and FSH tell you where.
The logic works like this:
- High LH and FSH alongside low testosterone points to a testicular problem: primary hypogonadism. The brain is signaling correctly; the testes are not responding.
- Low or inappropriately normal LH and FSH alongside low testosterone points to a hypothalamic-pituitary problem: secondary hypogonadism, as described in PMC's review of hypogonadism diagnosis (Carnegie, 2004). The signal itself is missing or too weak.
A repeat morning draw is standard practice before acting on a single low result, since testosterone fluctuates through the day and a one-off reading is not considered diagnostic on its own.
Primary vs Secondary Hypogonadism at a Glance
| Feature | Primary Hypogonadism | Secondary Hypogonadism |
|---|---|---|
| Origin | Testes | Hypothalamus or pituitary |
| LH/FSH pattern | High | Low or inappropriately normal |
| Common causes | Klinefelter syndrome, testicular injury, chemotherapy, aging testes | Pituitary tumor, obesity, opioid use, elevated prolactin |
| Fertility impact | Often significant | Sometimes reversible with underlying-cause treatment |
| Also called | Hypergonadotropic hypogonadism | Hypogonadotropic (central) hypogonadism |
Additional Testing That Refines the Diagnosis
A detailed history covering medication use, opioid exposure, head trauma, and mumps history helps narrow the likely category even before labs come back. A clinician who knows you take a chronic opioid, or who learns you had mumps as a teenager, is already thinking about specific pathways.
When LH and FSH come back low, prolactin and thyroid panels are ordered to rule out a pituitary source, consistent with BMJ Best Practice guidance (2025). Elevated prolactin in particular can suppress the entire hypothalamic-pituitary-gonadal axis and needs its own workup.
Pituitary MRI is reserved for cases with markedly low LH/FSH, visual symptoms, or other pituitary hormone abnormalities; it is not a routine first step for every low testosterone result. A karyotype test may be ordered when primary hypogonadism presents early in life or with physical exam findings suggestive of Klinefelter syndrome.
This layered approach, history first, targeted labs second, imaging only when indicated, keeps the workup proportional to what the initial numbers actually suggest.
Why the Distinction Changes the Care Plan
Secondary causes sometimes resolve, or partly resolve, by addressing the root driver: weight loss, discontinuing an opioid, or treating a prolactin-secreting tumor. Because the testes were never the problem, restoring the signal can restore function.
Primary causes generally do not reverse, since the testicular tissue itself is affected rather than the instructions it receives. Fertility counseling differs meaningfully between the two categories as well; some secondary hypogonadism responds to medications that restore the brain's signal rather than replacing testosterone directly, an option that is not available when the testes themselves cannot respond.
When testosterone therapy is part of the care plan, it is prescribed by a licensed clinician and compounded and dispensed by a 503A partner pharmacy, not manufactured in-house. That distinction matters for anyone comparing options, since compounded formulations are not FDA-approved in the way that brand-name molecules are; they follow a different regulatory pathway through state-licensed 503A pharmacies.
This is a general education framework, not individual medical advice. Interpreting your own LH, FSH, and testosterone pattern requires evaluation by a licensed clinician, not a self-read of lab numbers.
When to Talk to a Clinician About Low Testosterone Symptoms
Persistent fatigue, low libido, reduced muscle mass, or mood changes alongside a confirmed low testosterone result warrant a full hormone panel, not a testosterone test alone. Symptoms overlap too much between primary and secondary causes for guesswork to be useful.
EliteCare's state-licensed clinicians, available in all 50 states through LodeRx's platform, order and interpret the LH/FSH panel needed to classify the type before recommending next steps. LodeRx itself operates as a marketing platform connecting patients to that clinical care; it does not provide clinical services, dispense medication, or handle protected health information directly.
Before an intake, it helps to gather:
- Any history of chemotherapy, radiation, or testicular injury
- Current or past opioid use
- Unexplained pituitary symptoms such as vision changes or persistent headaches
- Prior testosterone or hormone lab results, if available
Review the TRT hub for a broader overview of testosterone replacement therapy candidacy, the bloodwork guide for what a baseline hormone panel typically includes, and the labs overview for how to prepare for a morning draw before your first intake.
As a compliance note, LodeRx holds a LegitScript Healthcare Merchant Certification, a healthcare merchant compliance and accreditation status, not a medical endorsement or FDA approval of any medication discussed here.
FAQ
How can I tell if I have primary or secondary hypogonadism? You cannot tell from symptoms alone; both types cause similar fatigue, low libido, and low testosterone readings. The distinction requires a blood panel measuring LH and FSH alongside testosterone. High LH/FSH points to a testicular (primary) cause; low or normal LH/FSH points to a hypothalamic-pituitary (secondary) cause. A licensed clinician interprets this pattern together with your history.
What is the difference between hypogonadism and low testosterone? Low testosterone is a lab finding, a number below the reference range. Hypogonadism is the clinical diagnosis that combines a confirmed low testosterone level with associated symptoms and, often, abnormal LH or FSH. Not everyone with a single low testosterone reading has hypogonadism; a repeat morning draw and symptom review are typically required first.
What is the most common cause of secondary hypogonadism? Obesity-related suppression of the hypothalamic-pituitary-gonadal axis is among the most frequently cited acquired causes, alongside chronic opioid use and elevated prolactin, according to sources including MedPage Today's review of acquired secondary hypogonadism (2016). Pituitary tumors are a less common but important cause that clinicians screen for with additional hormone testing.
Can secondary hypogonadism be treated or reversed? Some cases improve when the underlying driver is addressed, such as weight loss, stopping an opioid medication, or treating a prolactin-secreting pituitary tumor, because the signaling problem, not the testes, is the issue. Other cases require ongoing management. Whether reversal is possible depends on the specific cause and is determined by a clinician, not a general rule.
If your symptoms and a prior lab result suggest low testosterone, the next concrete step is a full hormone panel, testosterone, LH, and FSH together, reviewed by a licensed clinician who can determine which pattern you actually have before any treatment conversation begins.